semaglutide resting heart rate drop from GLP-1 meds : r/Semaglutide semaglutide high heart rate Have

Loux, M

Keeping a consistent dosing schedule ensures continued effectiveness

History & Development Semaglutide was developed by Novo Nordisk, a pharmaceutical company with a long-standing focus on diabetes and metabolic disorders

tirzepatide The newly approved Wegovy HD (semaglutide) 7.2 mg injection produced approximately 21% average weight loss in clinical trials in adults with obesity in the STEP UP trial, approaching the 22.5% weight loss reported with tirzepatide 15 mg in the SURMOUNT-1 trial

While this effect may help regulate appetite, blood sugar, and body weight, plaintiffs allege it can also lead to severe stomach issues in some patients